TMC Pharma Services can help to achieve better access to European markets

Your EU presence

The European pharmaceutical market is even larger than that of the USA, with over 490 million inhabitants in the 27 EU countries alone, compared to 307 million in the USA (figures from 2008, www.cia.gov). And, with new countries joining the EU, this is a rapidly expanding market. If your organisation does not yet have an office in Europe, now is the time to create one.

Procedures for obtaining marketing approval throughout all countries in the European Union now mean that eligible products can be submitted as just one marketing authorisation application, made centrally, for all member states.

Any pharmaceutical or biotech company with innovative products should have direct access to the European market place. To hold an EU market licence, you must have either an EU partner or an affiliate company in the EU.

TMC can set up a European operation of any size, with scope for any level of activity. We can:
• Create a company in your name with care-taking, contact and mailing possibilities
• Locate office facilities and experienced scientific and administrative staff to run a 'virtual' organisation
• Implement a full start-up company, from location of offices and recruitment of staff through to initiation of development activities and sales
• Act as your legal representative in the EU - a prerequisite for clinical trial applications
• Act as your EU company sponsor, as required for orphan drug designation or marketing application